Compare Cardiac Dimensions vs NeoChord
Customers evaluate the quality of Cardiac Dimensions's products using the following success metrics.
Overview
Cardiac Dimensions is 24 yrs old and is based in United States.
Cardiac Dimensions develops minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. Its initial technology platform, the CARILLON Mitral Contour System has been designed to address functional mitral regurgitation, utilizing a novel percutaneous approach. The company was founded in 2000 and is based in Kirkland, Washington.
NeoChord is 17 yrs old and is based in United States.
NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation, and is proven to resolve and restore normal mitral valve function. It was formerly known as mValve. The company was founded in 2007 and is based in St. Louis Park, Minnesota.
Demo Video
Leadership
Scott Wolf (Founder)
John Seaberg (Founder)
Funding
Investors
Lumira Ventures, Arboretum Ventures
Treo Venture, Baird Capital Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Cardiac Dimensions has not claimed their profile.
Work for Cardiac Dimensions? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cardiac Dimensions?
Claim your profile now.
Information not available because NeoChord has not claimed their profile.
Work for NeoChord? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for NeoChord?
Claim your profile now.